Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Outlook on the Continence Care Global Market to 2031 - by Product Type, Indication, End-user and Region


DUBLIN, Oct. 6, 2022 /PRNewswire/ -- The "Continence Care Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031" report has been added to  ResearchAndMarkets.com's offering.

Research and Markets Logo

This report on the global continence care market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031.

The report provides the overall revenue of the global continence care market for the period 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global continence care market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global continence care market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the global continence care market.

The report comprises an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global continence care market.

These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global continence care market. The next section of the continence care market report highlights the USPs, which includes, COVID-19 pandemic impact on industry (value chain and short/mid/long term impact), technological advancements, pricing analysis, reimbursement scenario by region/globally, key industrial events (licensing partnership/merger & acquisition), and Porter's five force analysis.

The report delves into the competition landscape of the global continence care market. Key players operating in the global continence care market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the continence care market in report.

Key Questions Answered in Continence Care Market Report

Key Topics Covered:

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Continence Care Market

4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Continence Care Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights
5.1. Technological Advancements
5.2. Pricing Analysis
5.3. Reimbursement Scenario, by Region/globally
5.4. Key Industrial Events (licensing partnership/merger & acquisition)
5.5. COVID-19 Impact Analysis
5.6. Porter's Five Force Analysis

6. Global Continence Care Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017-2031
6.3.1. Urinary Catheters
6.3.1.1. External Catheters
6.3.1.2. Indwelling Catheters
6.3.1.3. Intermittent Catheters
6.3.1.4. Catheter Accessories
6.3.2. Male Bodyworn Urinals
6.3.3. Mechanical Devices for Women with Urinary Incontinence
6.3.3.1. Urethral Inserts
6.3.3.2. Intravaginal Devices
6.3.4. Urine Drainage Bags & Accessories
6.3.4.1. Leg Drainage Bags
6.3.4.2. Night Drainage Bags
6.3.4.3. Accessories
6.3.5. Absorbents
6.3.6. Penile Clamps
6.3.7. Non-implantable Electrical Stimulation Devices
6.3.8. Others
6.4. Market Attractiveness Analysis, by Product Type

7. Global Continence Care Market Analysis and Forecast, by Indication
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Indication, 2017-2031
7.3.1. Urge Urinary Incontinence (UUI)
7.3.2. Stress Urinary Incontinence (SUI)
7.3.3. Mixed Urinary Incontinence (MUI)
7.3.4. Others
7.4. Market Attractiveness Analysis, by Indication

8. Global Continence Care Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017-2031
8.3.1. Acute Care Facilities
8.3.2. Long Term Care Facilities
8.3.3. Homecare
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user

9. Global Continence Care Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region

10. North America Continence Care Market Analysis and Forecast

11. Europe Continence Care Market Analysis and Forecast

12. Asia Pacific Continence Care Market Analysis and Forecast

13. Latin America Continence Care Market Analysis and Forecast

14. Middle East & Africa Continence Care Market Analysis and Forecast

15. Competitive Landscape
15.1. Market Share Analysis of Key Companies, by Region (2020)
15.2. Company Profiles
15.2.1. Abena A/S
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Product Portfolio
15.2.1.3. Strategic Overview
15.2.1.4. SWOT Analysis
15.2.2. Atlantic Therapeutics
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Product Portfolio
15.2.2.3. Strategic Overview
15.2.2.4. SWOT Analysis
15.2.3. Attends Healthcare Products, Inc.
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Product Portfolio
15.2.3.3. Strategic Overview
15.2.3.4. SWOT Analysis
15.2.4. B. Braun Melsungen AG
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. Financial Overview
15.2.4.4. Strategic Overview
15.2.4.5. SWOT Analysis
15.2.5. Beambridge Medical Ltd.
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. Strategic Overview
15.2.5.4. SWOT Analysis
15.2.6. Becton, Dickinson and Company
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Product Portfolio
15.2.6.3. Financial Overview
15.2.6.4. Strategic Overview
15.2.6.5. SWOT Analysis
15.2.7. Boston Scientific Corporation
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. Strategic Overview
15.2.7.4. SWOT Analysis
15.2.8. Coloplast A/S
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Product Portfolio
15.2.8.3. Financial Overview
15.2.8.4. Strategic Overview
15.2.8.5. SWOT Analysis
15.2.9. ConvaTec Group PLC
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Product Portfolio
15.2.9.3. Financial Overview
15.2.9.4. Strategic Overview
15.2.9.5. SWOT Analysis
15.2.10. Drylock Technologies
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Product Portfolio
15.2.10.3. Strategic Overview
15.2.10.4. SWOT Analysis
15.2.11. Hollister Incorporated
15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.11.2. Product Portfolio
15.2.11.3. Strategic Overview
15.2.11.4. SWOT Analysis
15.2.12. InControl Medical LLC
15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.12.2. Product Portfolio
15.2.12.3. Strategic Overview
15.2.12.4. SWOT Analysis
15.2.13. Kimberly-Clark Corporation
15.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.13.2. Product Portfolio
15.2.13.3. Financial Overview
15.2.13.4. Strategic Overview
15.2.13.5. SWOT Analysis
15.2.14. Optimum Medical Limited
15.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.14.2. Product Portfolio
15.2.14.3. Strategic Overview
15.2.14.4. SWOT Analysis
15.2.15. Pacey MedTech Ltd.
15.2.15.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.15.2. Product Portfolio
15.2.15.3. Strategic Overview
15.2.15.4. SWOT Analysis
15.2.16. Renew Medical, Inc.
15.2.16.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.16.2. Product Portfolio
15.2.16.3. Strategic Overview
15.2.16.4. SWOT Analysis
15.2.17. Uresta
15.2.17.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.17.2. Product Portfolio
15.2.17.3. Strategic Overview
15.2.17.4. SWOT Analysis
15.2.18. Urocare Products, Inc.
15.2.18.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.18.2. Product Portfolio
15.2.18.3. Strategic Overview
15.2.18.4. SWOT Analysis
15.2.19. Vesiflo, Inc.
15.2.19.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.19.2. Product Portfolio
15.2.19.3. Strategic Overview
15.2.19.4. SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/s1pi4f

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets


These press releases may also interest you

at 21:00
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

at 19:30
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:51
Banco Latinoamericano de Comercio Exterior, S.A. , a Panama-based multinational bank originally established by the central banks of 23 Latin-American and Caribbean countries to promote foreign trade and economic integration in the Region, announced...

at 17:20
Providing a comprehensive overview of NOVAGOLD's Environmental, Social and Governance (ESG) performance, emphasizing remarkable health and safety records, steadfast dedication to environmental protection, continuous community investment, extensive...

at 16:45
Dogness (International) Corporation ("Dogness" or the "Company") , a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet products, today announced its financial results for the six months ended December...



News published on and distributed by: